Shoulder Innovations (FRA:VB3) Total Operating Expense: €62.20 Mil (TTM As of Mar. 2026)


FRA:VB3 Shoulder Innovations Inc FRA:VB3
18 GF Score
Price €18.70
! 6 Warning Signs
View Full Analysis

What is Shoulder Innovations Total Operating Expense?

Shoulder Innovations FRA:VB3 +8.72% 18 Total Operating Expense is €62.20 Mil as of Mar. 2026. GuruFocus rates FRA:VB3 with a GF Score™ of 18/100. The stock has 6 warning signs investors should review.

Shoulder Innovations's Total Operating Expense for the three months ended in Mar. 2026 was €19.00 Mil. Shoulder Innovations's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was €62.20 Mil.

Shoulder Innovations Total Operating Expense Related Terms

Shoulder Innovations Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Shoulder Innovations's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shoulder Innovations Total Operating Expense Chart

Shoulder Innovations Annual Data
Trend Dec23 Dec24 Dec25
Total Operating Expense
23.97 37.24 53.38

Shoulder Innovations Quarterly Data
Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.18 12.36 14.15 16.70 19.00
FRA:VB3
18GF Score
Shoulder Innovations Inc FRA:VB3
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shoulder Innovations Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €62.20 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of €62.20 Mil mean?
Shoulder Innovations (FRA:VB3) has a Total Operating Expense of €62.20 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Shoulder Innovations and its competitors.
Is Shoulder Innovations' Total Operating Expense too high?
Shoulder Innovations' current Total Operating Expense is €62.20 Mil. Overall, Shoulder Innovations has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Shoulder Innovations' Total Operating Expense compare to ELMD and MASS?
Shoulder Innovations' Total Operating Expense of €62.20 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Medical Devices & Instruments company?
A good Total Operating Expense depends on the Medical Devices & Instruments industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Shoulder Innovations and its competitors. Shoulder Innovations's current Total Operating Expense is €62.20 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shoulder Innovations stock overvalued right now?
Shoulder Innovations (FRA:VB3) has a current Total Operating Expense of €62.20 Mil. The current Total Operating Expense is €62.20 Mil. Shoulder Innovations' overall GF Score™ is 18/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Shoulder Innovations (FRA:VB3), the current Total Operating Expense is €62.20 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Shoulder Innovations Business Description

Other Exchanges SI:USA
Address 1535 Steele Avenue SW, Suite B, Grand Rapids, MI, USA, 49507
Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System. Geographically, the company operates in United States and are planning to expand.
18GF Score

Get the complete analysis for FRA:VB3

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€18.70
Price